Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

Laura Loomer, the controversial far-right activist with a direct line to President Donald Trump, has taken credit for a slew ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Dave Ramsey explains Medicare and Medicaid, highlighting differences and eligibility. Trump launches health tracking system ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) traded higher in the premarket on Friday after The Washington ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

President Trump's federal hiring freeze and decision to fire Bureau of Labor Statistics Commissioner Erika McEntarfer raise questions about the validity of inflation data.

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.